-
1
-
-
36348941409
-
-
UNAIDS, Geneva, Accessed on 15 Dec 2011, UNAIDS
-
UNAIDS AIDS epidemic update 2011 2011, UNAIDS, Geneva, http://www.unaids.org/en/dataanalysis/epidemiol, Accessed on 15 Dec 2011, UNAIDS.
-
(2011)
AIDS epidemic update 2011
-
-
-
2
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
-
10.1056/NEJM199803263381301, 9516219
-
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853-860. 10.1056/NEJM199803263381301, 9516219.
-
(1998)
N Engl J Med
, vol.338
, pp. 853-860
-
-
Palella, F.J.1
Delaney, K.M.2
Moorman, A.C.3
Loveless, M.O.4
Fuhrer, J.5
Satten, G.A.6
Aschman, D.J.7
Holmberg, S.D.8
-
3
-
-
0033999310
-
Welcome therapy may have unwelcome effects
-
HIV-associated metabolic and morphologic abnormality syndrome
-
Cohan GR, HIV-associated metabolic and morphologic abnormality syndrome Welcome therapy may have unwelcome effects. Postgrad Med 2000, 107:141-146. HIV-associated metabolic and morphologic abnormality syndrome.
-
(2000)
Postgrad Med
, vol.107
, pp. 141-146
-
-
Cohan, G.R.1
-
4
-
-
15844412978
-
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort
-
10.1111/j.1468-1293.2005.00273.x, 15807717
-
El-Sadr W, Mullin C, Carr A, Gibert C, Rappoport C, Visnegarwala F, Grunfeld C, Raghavan S. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort. HIV Med 2005, 6:114-121. 10.1111/j.1468-1293.2005.00273.x, 15807717.
-
(2005)
HIV Med
, vol.6
, pp. 114-121
-
-
El-Sadr, W.1
Mullin, C.2
Carr, A.3
Gibert, C.4
Rappoport, C.5
Visnegarwala, F.6
Grunfeld, C.7
Raghavan, S.8
-
5
-
-
3042848853
-
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviralnaive patients: a 3-year randomized trial
-
10.1001/jama.292.2.191, 15249568, 903 Study Group
-
Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK, 903 Study Group Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviralnaive patients: a 3-year randomized trial. JAMA 2004, 292:191-201. 10.1001/jama.292.2.191, 15249568, 903 Study Group.
-
(2004)
JAMA
, vol.292
, pp. 191-201
-
-
Gallant, J.E.1
Staszewski, S.2
Pozniak, A.L.3
DeJesus, E.4
Suleiman, J.M.5
Miller, M.D.6
Coakley, D.F.7
Lu, B.8
Toole, J.J.9
Cheng, A.K.10
-
6
-
-
34247630552
-
Association of serum lipid levels with HIV sero-status, specific antiretroviral agents and treatment regimens
-
Anastos K, Lu D, Shi Q, Tien PC, Kaplan RC, Hessol NA, Cole S, Vigen C, Cohen M, Young M, Tien, Phyllis C, Vigen C, Justman J. Association of serum lipid levels with HIV sero-status, specific antiretroviral agents and treatment regimens. J Acquir Immune Defic Syndr 2007, 459:34-42.
-
(2007)
J Acquir Immune Defic Syndr
, vol.459
, pp. 34-42
-
-
Anastos, K.1
Lu, D.2
Shi, Q.3
Tien, P.C.4
Kaplan, R.C.5
Hessol, N.A.6
Cole, S.7
Vigen, C.8
Cohen, M.9
Young, M.10
Tien11
Phyllis, C.12
Vigen, C.13
Justman, J.14
-
7
-
-
0035824764
-
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an antiatherogenic lipid profile
-
10.1097/00002030-200112070-00008, 11740191, Atlantic Study Team
-
Van der Valk M, Kastelein JJ, Murphy RL, Van Leth F, Katlama C, Horban A, Glesby M, Behrens G, Clotet B, Stellato RK, Molhuizen HO, Reiss P, Atlantic Study Team Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an antiatherogenic lipid profile. AIDS 2001, 15:2407-2414. 10.1097/00002030-200112070-00008, 11740191, Atlantic Study Team.
-
(2001)
AIDS
, vol.15
, pp. 2407-2414
-
-
Van der Valk, M.1
Kastelein, J.J.2
Murphy, R.L.3
Van Leth, F.4
Katlama, C.5
Horban, A.6
Glesby, M.7
Behrens, G.8
Clotet, B.9
Stellato, R.K.10
Molhuizen, H.O.11
Reiss, P.12
-
8
-
-
24044530462
-
Lipid profiles for antiretroviral-naïve patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study
-
Young J, Weber R, Rickenbach M, Furrer H, Bernasconi E, Hirschel B, Tarr PE, Vernazza P, Battegay M, Bucher HC. Lipid profiles for antiretroviral-naïve patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Antivir Ther 2005, 10:585-591.
-
(2005)
Antivir Ther
, vol.10
, pp. 585-591
-
-
Young, J.1
Weber, R.2
Rickenbach, M.3
Furrer, H.4
Bernasconi, E.5
Hirschel, B.6
Tarr, P.E.7
Vernazza, P.8
Battegay, M.9
Bucher, H.C.10
-
9
-
-
0345064200
-
Combination antiretroviral therapy and the risk of myocardial infarction
-
Friis-Moller N, Sabin C, Weber R, Monforte A, El-Sadr W, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law M, Kirk O, Phillips A, Lundgren J, Bartsch G, Dabis F, Loeliger H, Tressler R, Weller I, Sawitz A, Rickenbach M, Pezzotti P, Krum E, Meester R, Lavignolle V, Sundström B, Fontas E, Torres F, Petoumenos K, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003, 349:1993-2003.
-
(2003)
N Engl J Med
, vol.349
, pp. 1993-2003
-
-
Friis-Moller, N.1
Sabin, C.2
Weber, R.3
Monforte, A.4
El-Sadr, W.5
Reiss, P.6
Thiébaut, R.7
Morfeldt, L.8
De Wit, S.9
Pradier, C.10
Calvo, G.11
Law, M.12
Kirk, O.13
Phillips, A.14
Lundgren, J.15
Bartsch, G.16
Dabis, F.17
Loeliger, H.18
Tressler, R.19
Weller, I.20
Sawitz, A.21
Rickenbach, M.22
Pezzotti, P.23
Krum, E.24
Meester, R.25
Lavignolle, V.26
Sundström, B.27
Fontas, E.28
Torres, F.29
Petoumenos, K.30
more..
-
11
-
-
42449087791
-
Changes in lipid profile over 24months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda
-
10.1097/QAI.0b013e31815e7453, 18398971
-
Buchacz K, Weidle PJ, Moore D, Were W, Mermin J, Downing R, Kigozi A, Borkowf CB, Ndazima V, Brooks JT. Changes in lipid profile over 24months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr 2008, 47:304-311. 10.1097/QAI.0b013e31815e7453, 18398971.
-
(2008)
J Acquir Immune Defic Syndr
, vol.47
, pp. 304-311
-
-
Buchacz, K.1
Weidle, P.J.2
Moore, D.3
Were, W.4
Mermin, J.5
Downing, R.6
Kigozi, A.7
Borkowf, C.B.8
Ndazima, V.9
Brooks, J.T.10
-
12
-
-
67649148055
-
Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin
-
Zannou DM, Denoeud L, Lacombe K, Amoussou-Guenou D, Bashi J, Akakpo J, Gougounon A, Akondé A, Adé G, Houngbé F, Girard PM. Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin. Antivir Ther 2009, 14:371-380.
-
(2009)
Antivir Ther
, vol.14
, pp. 371-380
-
-
Zannou, D.M.1
Denoeud, L.2
Lacombe, K.3
Amoussou-Guenou, D.4
Bashi, J.5
Akakpo, J.6
Gougounon, A.7
Akondé, A.8
Adé, G.9
Houngbé, F.10
Girard, P.M.11
-
13
-
-
0037126526
-
The third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report
-
National Cholesterol Education Program (NCEP)
-
National Cholesterol Education Program (NCEP) The third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, 106:3143-3421. National Cholesterol Education Program (NCEP).
-
(2002)
Circulation
, vol.106
, pp. 3143-3421
-
-
-
14
-
-
80053341921
-
First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study
-
10.1186/1742-6405-8-33, 3197472, 21943115
-
Pefura Yone EW, Betyoumin AF, Kengne AP, Folefack FJK, Ngogang J. First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study. AIDS Res Ther 2011, 8:33. 10.1186/1742-6405-8-33, 3197472, 21943115.
-
(2011)
AIDS Res Ther
, vol.8
, pp. 33
-
-
Pefura Yone, E.W.1
Betyoumin, A.F.2
Kengne, A.P.3
Folefack, F.J.K.4
Ngogang, J.5
-
15
-
-
43149121343
-
Prevalence of dyslipidemia and dysglycaemia in HIV infected patients
-
Manuthu EM, Joshi MD, Lule GN, Karari E. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients. East Afr Med J 2008, 85:10-17.
-
(2008)
East Afr Med J
, vol.85
, pp. 10-17
-
-
Manuthu, E.M.1
Joshi, M.D.2
Lule, G.N.3
Karari, E.4
-
16
-
-
28344452695
-
Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients
-
10.1016/j.atherosclerosis.2005.04.013, 15935358
-
Asztalos BF, Schaefer EJ, Horvath KV, Cox CE, Skinner S, Gerrior J, Gorbach SL, Christine Wanke C. Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients. Atherosclerosis 2006, 184:72-77. 10.1016/j.atherosclerosis.2005.04.013, 15935358.
-
(2006)
Atherosclerosis
, vol.184
, pp. 72-77
-
-
Asztalos, B.F.1
Schaefer, E.J.2
Horvath, K.V.3
Cox, C.E.4
Skinner, S.5
Gerrior, J.6
Gorbach, S.L.7
Christine Wanke, C.8
-
17
-
-
33746233466
-
Cardiovascular disease in HIV infection
-
10.1016/j.ahj.2005.07.030, 16781213
-
Sudano I, Spieker LE, Noll G, Corti R, Weber R, Lüscher TF. Cardiovascular disease in HIV infection. Am Heart J 2006, 151:1147-1155. 10.1016/j.ahj.2005.07.030, 16781213.
-
(2006)
Am Heart J
, vol.151
, pp. 1147-1155
-
-
Sudano, I.1
Spieker, L.E.2
Noll, G.3
Corti, R.4
Weber, R.5
Lüscher, T.F.6
-
18
-
-
79959625616
-
Dyslipidemia in AIDS patients on highly active antiretroviral therapy
-
Nery MW, Martelli CMT, Turchi MD. Dyslipidemia in AIDS patients on highly active antiretroviral therapy. Braz J Infect Dis 2011, 15:151-155.
-
(2011)
Braz J Infect Dis
, vol.15
, pp. 151-155
-
-
Nery, M.W.1
Martelli, C.M.T.2
Turchi, M.D.3
-
19
-
-
77953407183
-
HAART and lipid metabolism in a resource poor West African setting
-
Ogundahunsi O, Oyegunle V, Ogun S, Odusoga O, Daniel O. HAART and lipid metabolism in a resource poor West African setting. Afr J Biomed Res 2010, 11:27-31.
-
(2010)
Afr J Biomed Res
, vol.11
, pp. 27-31
-
-
Ogundahunsi, O.1
Oyegunle, V.2
Ogun, S.3
Odusoga, O.4
Daniel, O.5
-
20
-
-
47849123028
-
High-density lipoprotein cholesterol in HIV-infected patients: evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition
-
10.1089/apc.2007.0186, 18479224
-
Bernal E, Masiá M, Padilla S, Gutiérrez F. High-density lipoprotein cholesterol in HIV-infected patients: evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition. AIDS Patient Care STDS 2008, 22:569-575. 10.1089/apc.2007.0186, 18479224.
-
(2008)
AIDS Patient Care STDS
, vol.22
, pp. 569-575
-
-
Bernal, E.1
Masiá, M.2
Padilla, S.3
Gutiérrez, F.4
-
21
-
-
84869114202
-
Prevalence of Lipodystrophy and Dyslipidemia among Patients with HIV infection on generic ART in Rural South India
-
Kalyanasundaram AP, Jacob SM, Hemalatha R, Sivakumar MR. Prevalence of Lipodystrophy and Dyslipidemia among Patients with HIV infection on generic ART in Rural South India. JIAPAC 2011, 000:1-6.
-
(2011)
JIAPAC
, vol.0
, pp. 1-6
-
-
Kalyanasundaram, A.P.1
Jacob, S.M.2
Hemalatha, R.3
Sivakumar, M.R.4
-
22
-
-
80455144753
-
Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil
-
10.1590/S0100-879X2011007500129, 22052375
-
Ceccato M, Bonolo P, Souza Neto A, Araújo F, Freitas M. Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil. Braz J Med Biol Res 2011, 44:1177-1178. 10.1590/S0100-879X2011007500129, 22052375.
-
(2011)
Braz J Med Biol Res
, vol.44
, pp. 1177-1178
-
-
Ceccato, M.1
Bonolo, P.2
Souza Neto, A.3
Araújo, F.4
Freitas, M.5
-
23
-
-
15744367156
-
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral therapy-naïve patients infected with HIV-1
-
10.1371/journal.pmed.0010019, 523838, 15526045
-
van Leth F, Phanuphak P, Stroes E, Gazzard B, Cahn P, Raffi F, Wood R, Bloch M, Katlama C, Kastelein JJ, Schechter M, Murphy RL, Horban A, Hall DB, Lange JM, Reiss P. Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral therapy-naïve patients infected with HIV-1. PLoS Med 2004, 1:e19. 10.1371/journal.pmed.0010019, 523838, 15526045.
-
(2004)
PLoS Med
, vol.1
-
-
van Leth, F.1
Phanuphak, P.2
Stroes, E.3
Gazzard, B.4
Cahn, P.5
Raffi, F.6
Wood, R.7
Bloch, M.8
Katlama, C.9
Kastelein, J.J.10
Schechter, M.11
Murphy, R.L.12
Horban, A.13
Hall, D.B.14
Lange, J.M.15
Reiss, P.16
-
24
-
-
79951824946
-
Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in India
-
10.1093/cid/ciq195, 3060904, 21252141
-
Padmapriyadarsini C, Ramesh Kumar S, Terrin N, Narendran G, Menon PA, Ramachandran G, Subramanyan S, Venkatesan P, Wanke C, Swaminathan S. Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in India. Clin Infect Dis 2011, 52:540-546. 10.1093/cid/ciq195, 3060904, 21252141.
-
(2011)
Clin Infect Dis
, vol.52
, pp. 540-546
-
-
Padmapriyadarsini, C.1
Ramesh Kumar, S.2
Terrin, N.3
Narendran, G.4
Menon, P.A.5
Ramachandran, G.6
Subramanyan, S.7
Venkatesan, P.8
Wanke, C.9
Swaminathan, S.10
-
25
-
-
79952111189
-
Dyslipidemia and its Treatment in HIV Infection
-
3189481, 20921577
-
Grunfeld C. Dyslipidemia and its Treatment in HIV Infection. Top HIV Med 2010, 18:112-118. 3189481, 20921577.
-
(2010)
Top HIV Med
, vol.18
, pp. 112-118
-
-
Grunfeld, C.1
-
26
-
-
6044244839
-
Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical studies
-
10.1385/CT:4:3:243, 15470272
-
Bozkurt B. Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical studies. Cardiovasc Toxicol 2004, 4:243-260. 10.1385/CT:4:3:243, 15470272.
-
(2004)
Cardiovasc Toxicol
, vol.4
, pp. 243-260
-
-
Bozkurt, B.1
-
27
-
-
76649085856
-
Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients
-
Domingos H, Cunha RV, Paniago AM, Martins DM, Elkhoury EB, Souza AS. Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients. Braz J Infect Dis 2009, 13:130-136.
-
(2009)
Braz J Infect Dis
, vol.13
, pp. 130-136
-
-
Domingos, H.1
Cunha, R.V.2
Paniago, A.M.3
Martins, D.M.4
Elkhoury, E.B.5
Souza, A.S.6
|